Intestinal‐type GC patients tended to express low levels of ANGPTL1 (P < .0001), ANGPTL2 (P < .0001), and ANGPTL4 (P = .0357) compared to patients with mixed‐ and diffuse‐type GC. This evidence concerns the gene ANGPTL1 and gastric cancer.